Biotech investors might have had an exciting year in 2019 with an impressive amount of new drug approvals. There were 14 notable bankruptcies last year as well, the highest since 2011. Although it’s less common to see a company declare bankruptcy in the biotech sector than in other industries, […]
Click here to view original web page at newyork.citybizlist.com